rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

ArriVent BioPharma, Inc.

AVBP · Nasdaq

Health CareBiotechnologyNot moving yet

AVBP stood above a rising 150-day average in 39 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 41.8% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 4
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$26.0M
Officials’ trades on record
0
Institutions holding
155 (+21)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 39 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$25.0M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months2
Buyers · sellers0 · 2
WhoDidSharesTraded
Hillhouse Investment Management, Ltd.10% ownersold555,555at $23.3710 Dec 2025filed 3 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders155+21 on the quarter
New · exited39 · 17
Reported value$1.6B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
MONTANOVA CAPITAL, LLCadded · filed 14 Aug 20264,515,531$156.9M+114,448+2.6%
INFINITUM ASSET MANAGEMENT, LLCadded · filed 14 Aug 20264,438,384$154.2M+289,461+7.0%
HHLR ADVISORS, LTD.unchanged · filed 14 Aug 20263,929,117$136.5M00.0%
BlackRock, Inc.added · filed 7 Aug 20263,250,396$112.9M+720,095+28.5%
ORBIMED ADVISORS LLCunchanged · filed 14 Aug 20263,027,328$105.2M00.0%
FMR LLCreduced · filed 13 Aug 20262,778,959$96.5M-237,173−7.9%
Octagon Capital Advisors LPunchanged · filed 14 Aug 20261,971,054$68.5M00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,774,873$61.7M+245,980+16.1%
Sofinnova Investments, Inc.unchanged · filed 14 Aug 20261,696,752$58.9M00.0%
STATE STREET CORPadded · filed 7 Aug 20261,692,986$58.8M+271,571+19.1%
31 Mar 2024 – 30 Jun 2026
54103151Mar 24Sep 24Jun 25Dec 25Jun 26

Everyone who traded it

Chris Nolet Company insiderDirector · last 18 Jun 20260 · 0
John Hohneker Company insiderDirector · last 18 Jun 20260 · 0
Kristine Peterson Company insiderDirector · last 18 Jun 20260 · 0
Merdad Parsey Company insiderDirector · last 18 Jun 20260 · 0
James Paul Kastenmayer Company insiderGeneral Counsel · last 2 Feb 20260 · 0
Robin LaChapelle Company insiderChief Operating Officer · last 2 Feb 20260 · 0
Stuart Lutzker Company insiderPresident of R&D · last 2 Feb 20260 · 0
Winston Kung Company insiderChief Financial Officer · last 2 Feb 20260 · 0
Zhengbin Yao Company insiderPresident and CEO · last 2 Feb 20260 · 0
Hhlr Advisors, Ltd. Company insider10% owner · last 10 Dec 20251 · 1
HILLHOUSE INVESTMENT MANAGEMENT, LTD. Company insider10% owner · last 10 Dec 20250 · 1
Carl L. Gordon Company insiderDirector, 10% owner · last 30 Jan 20241 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-57.8%
Share count trendFY 2025 · to 4 Mar 20264.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$45.5M

Analyst forecasts

No analyst forecasts yet.